Drugs / RDG-17012
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03495739 | Feb → Jun 2018 | — | Huons Co., Ltd. | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | RDG-17012 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03495739 ↗ |
| Known as | Dabigatran Etexilate Tosylate | “RDG-17012(Dabigatran Etexilate Tosylate)” NCT03495739 ↗ |